Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Sasakawa-India Leprosy Foundation, New Delhi, India.
PLoS Negl Trop Dis. 2021 Sep 20;15(9):e0009769. doi: 10.1371/journal.pntd.0009769. eCollection 2021 Sep.
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, the annual new case detection in 2019 was 202,189 globally. Measuring endemicity levels and burden in leprosy lacks a uniform approach. As a result, the assessment of leprosy endemicity or burden are not comparable over time and across countries and regions. This can make program planning and evaluation difficult. This study aims to identify relevant metrics and methods for measuring and classifying leprosy endemicity and burden at (sub)national level.
We used a mixed-method approach combining findings from a systematic literature review and a Delphi survey. The literature search was conducted in seven databases, searching for endemicity, burden and leprosy. We reviewed the available evidence on the usage of indicators, classification levels, and scoring methods to measure and classify endemicity and burden. A two round Delphi survey was conducted to ask experts to rank and weigh indicators, classification levels, and scoring methods.
The literature review showed variation of indicators, levels, and cut-off values to measure leprosy endemicity and/or burden. The most used indicators for endemicity include new case detection rate (NCDR), new cases among children and new cases with grade 2 disability. For burden these include NCDR, MB cases, and prevalence. The classification levels 'high' and 'low' were most important. It was considered most relevant to use separate scoring methods for endemicity and burden. The scores would be derived by use of multiple indicators.
There is great variation in the existing method for measuring endemicity and burden across countries and regions. Our findings contribute to establishing a standardized uniform approach to measure and classify leprosy endemicity and burden at (sub)national level, which would allow effective communication and planning of intervention strategies.
麻风病是一种由麻风分枝杆菌引起的慢性传染病,2019 年全球新发病例检出数为 202189 例。衡量麻风病的流行程度和负担缺乏统一的方法。因此,麻风病的流行程度或负担评估在时间和国家/地区之间无法进行比较。这使得规划和评估计划变得困难。本研究旨在确定在(亚)国家层面衡量和分类麻风病流行程度和负担的相关指标和方法。
我们采用混合方法,结合系统文献综述和德尔菲调查的结果。文献检索在七个数据库中进行,搜索流行程度、负担和麻风病。我们回顾了关于使用指标、分类水平和评分方法来衡量和分类流行程度和负担的现有证据。进行了两轮德尔菲调查,要求专家对指标、分类水平和评分方法进行排名和加权。
文献综述显示,衡量麻风病流行程度和/或负担的指标、水平和截止值存在差异。流行程度最常用的指标包括新病例检出率(NCDR)、儿童新病例和 2 级残疾新病例。用于负担的指标包括 NCDR、MB 病例和患病率。“高”和“低”的分类水平最为重要。认为最相关的是使用单独的评分方法来衡量流行程度和负担。分数将通过使用多个指标来得出。
各国和各地区衡量流行程度和负担的现有方法存在很大差异。我们的研究结果有助于建立一种标准化的统一方法来衡量和分类(亚)国家层面的麻风病流行程度和负担,从而能够有效地进行干预策略的沟通和规划。